U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. Jobs and Training at FDA
  4. Scientific Internships, Fellowships / Trainees and Non-U.S. Citizens
  5. FDA Pharmacy Student Experiential Program
  6. DDI Webinar- “An Overview of FDA’s Expanded Access Process and the New Individual Patient Expanded Access Application”- July 12, 2016
  1. FDA Pharmacy Student Experiential Program

DDI Webinar- “An Overview of FDA’s Expanded Access Process and the New Individual Patient Expanded Access Application”- July 12, 2016

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all healthcare professionals, pharmacy students, nurse practitioner students, physician assistants, and medical students. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!

 
On July 12, 2016, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: An Overview of FDA’s Expanded Access Process and the New Individual Patient Expanded Access Application. The panel presenters were Richard Klein, Director of the FDA’s Patient Liaison Program in the Office of Health and Constituent Affairs (OHCA), Peter Lurie MD, MPH, Associate Commissioner for Public Health Strategy and Analysis, Office of the Commissioner  and Colleen Locicero, RPh, Associate Director for Regulatory Affairs in the Office of Drug Evaluation I in FDA’s Center for Drug Evaluation and Research (CDER). The presenters discussed and summarized the purpose of FDA’s expanded access program, including the types of expanded access requests accepted by FDA. They also described the requirements for requesting individual expanded access and the costs physicians may charge patients for single patient expanded access. Finally, they reviewed and explained how to submit single patient IND expanded access requests to the FDA using the new FDA Form 3926.

 

Download Presentation Slides: An Overview of FDA’s Expanded Access Process and the New Individual Patient Expanded Access Application (PDF - 3.5MB)

View Webinar: https://collaboration.fda.gov/p3r21p6z2ry/

Activity Outline and Continuing Education Information: Expanded Access Activity Outline (PDF - 66KB)

If you have never attended an Adobe Connect meeting before:

Test your connection: https://collaboration.fda.gov/common/help/en/support/meeting_test.htm

Get a quick overview: http://www.adobe.com/go/connectpro_overview 

Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.

ResourcesForYou

Back to Top